Innate Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Innate Pharma and buy or sell other stocks, ETFs, and their options commission-free!About IPHA
Innate Pharma SA is a global, clinical-stage biotechnology company, which engages in developing immunotherapies for cancer patients. Its product pipeline includes Lacutamab, Monalizumab, Avdoralimab, and IPH62.
CEOJonathan Dickinson
CEOJonathan Dickinson
Employees163
Employees163
HeadquartersMarseille, Provence-Alpes-Cote-dAzur
HeadquartersMarseille, Provence-Alpes-Cote-dAzur
Founded1999
Founded1999
Employees163
Employees163
IPHA Key Statistics
Market cap170.85M
Market cap170.85M
Price-Earnings ratio-2.88
Price-Earnings ratio-2.88
Dividend yield—
Dividend yield—
Average volume9.98K
Average volume9.98K
High today$1.80
High today$1.80
Low today$1.71
Low today$1.71
Open price$1.71
Open price$1.71
Volume1.84K
Volume1.84K
52 Week high$2.62
52 Week high$2.62
52 Week low$1.17
52 Week low$1.17
IPHA News
TipRanks 5d
Innate Pharma SA Q2 2024 Earnings Report - Results, Call & Slides - TipRanks...
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.